Literature DB >> 19450952

A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

S Kristian Hill1, James L Reilly, Margret S H Harris, Cherise Rosen, Robert W Marvin, Ovidio Deleon, John A Sweeney.   

Abstract

The severity and profile of cognitive dysfunction in first episode schizophrenia and psychotic affective disorders were compared before and after antipsychotic treatment. Parallel recruitment of consecutively admitted study-eligible first-episode psychotic patients (30 schizophrenia, 22 bipolar with psychosis, and 21 psychotic depression) reduced confounds of acute and chronic disease/medication effects as well as differential treatment and course. Patient groups completed a neuropsychological battery and were demographically similar to healthy controls (n=41) studied in parallel. Prior to treatment, schizophrenia patients displayed significant deficits in all cognitive domains. The two psychotic affective groups were also impaired overall, generally performing intermediate between the schizophrenia and healthy comparison groups. No profile differences in neuropsychological deficits were observed across patient groups. Following 6 weeks of treatment, no patient group improved more than practice effects seen in healthy individuals, and level of performance improvement was similar for affective psychosis and schizophrenia groups. Although less severe in psychotic affective disorders, similar profiles of generalized neuropsychological deficits were observed across patient groups. Recovery of cognitive function after clinical stabilization was similar in mood disorders and schizophrenia. To the extent that these findings are generalizable, neuropsychological deficits in psychotic affective disorders, like schizophrenia, may be trait-like deficits with persistent functional implications.

Entities:  

Mesh:

Year:  2009        PMID: 19450952      PMCID: PMC2773205          DOI: 10.1016/j.schres.2009.04.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  47 in total

1.  Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia.

Authors:  Leah H Rubin; Gretchen L Haas; Matcheri S Keshavan; John A Sweeney; Pauline M Maki
Journal:  Neuropsychopharmacology       Date:  2007-03-28       Impact factor: 7.853

2.  Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.

Authors:  James L Reilly; Margret S H Harris; Tin T Khine; Matcheri S Keshavan; John A Sweeney
Journal:  Biol Psychiatry       Date:  2007-02-14       Impact factor: 13.382

3.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Authors:  Michael F Green
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

4.  Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.

Authors:  James L Reilly; Margret S H Harris; Matcheri S Keshavan; John A Sweeney
Journal:  Arch Gen Psychiatry       Date:  2006-11

5.  Neuropsychological functioning in bipolar disorder and schizophrenia.

Authors:  David J Schretlen; Nicola G Cascella; Stephen M Meyer; Lisle R Kingery; S Marc Testa; Cynthia A Munro; Ann E Pulver; Paul Rivkin; Vani A Rao; Catherine M Diaz-Asper; Faith B Dickerson; Robert H Yolken; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2006-12-11       Impact factor: 13.382

Review 6.  Endophenotypes in the genetic analyses of mental disorders.

Authors:  Tyrone D Cannon; Matthew C Keller
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

Authors:  Terry E Goldberg; Robert S Goldman; Katherine E Burdick; Anil K Malhotra; Todd Lencz; Raman C Patel; Margaret G Woerner; Nina R Schooler; John M Kane; Delbert G Robinson
Journal:  Arch Gen Psychiatry       Date:  2007-10

8.  Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Richard S E Keefe; John A Sweeney; Hongbin Gu; Robert M Hamer; Diana O Perkins; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

9.  The neurocognitive signature of psychotic bipolar disorder.

Authors:  David C Glahn; Carrie E Bearden; Marcela Barguil; Jennifer Barrett; Abraham Reichenberg; Charles L Bowden; Jair C Soares; Dawn I Velligan
Journal:  Biol Psychiatry       Date:  2007-06-01       Impact factor: 13.382

10.  Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

Authors:  Joel Raskin; Curtis G Wiltse; Alan Siegal; Javaid Sheikh; Jimmy Xu; James J Dinkel; Benjamin T Rotz; Richard C Mohs
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

View more
  41 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

2.  Using the cognitive assessment interview to screen cognitive impairment in psychosis.

Authors:  Ana M Sánchez-Torres; María Rosa Elosúa; Ruth Lorente-Omeñaca; Lucía Moreno-Izco; Victor Peralta; Joseph Ventura; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06-06       Impact factor: 5.270

3.  Facial emotion recognition in first-episode schizophrenia and bipolar disorder with psychosis.

Authors:  Alexander R Daros; Anthony C Ruocco; James L Reilly; Margret S H Harris; John A Sweeney
Journal:  Schizophr Res       Date:  2014-01-21       Impact factor: 4.939

4.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

5.  Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.

Authors:  Weihong Lu; Chen Zhang; Zhenghui Yi; Zezhi Li; Zhiguo Wu; Yiru Fang
Journal:  J Mol Neurosci       Date:  2012-04-03       Impact factor: 3.444

6.  Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.

Authors:  Sarah K Keedy; Jeffrey R Bishop; Peter J Weiden; John A Sweeney; Cherise Rosen; Robert Marvin; James L Reilly
Journal:  Schizophr Res       Date:  2014-08-08       Impact factor: 4.939

7.  Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model.

Authors:  Laura Pina-Camacho; Juan Garcia-Prieto; Mara Parellada; Josefina Castro-Fornieles; Ana M Gonzalez-Pinto; Igor Bombin; Montserrat Graell; Beatriz Paya; Marta Rapado-Castro; Joost Janssen; Inmaculada Baeza; Francisco Del Pozo; Manuel Desco; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-11       Impact factor: 4.785

8.  Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.

Authors:  Amanda L Rodrigue; Jennifer E McDowell; Neeraj Tandon; Matcheri S Keshavan; Carol A Tamminga; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons; Brett A Clementz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-31

Review 9.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

10.  Cognitive impairment in affective psychoses: a meta-analysis.

Authors:  Emre Bora; Murat Yücel; Christos Pantelis
Journal:  Schizophr Bull       Date:  2009-09-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.